Literature DB >> 28934002

Estimating the Optimal Personalized Treatment Strategy Based on Selected Variables to Prolong Survival via Random Survival Forest with Weighted Bootstrap.

Jincheng Shen1, Lu Wang2, Stephanie Daignault2, Daniel E Spratt3, Todd M Morgan4, Jeremy M G Taylor2.   

Abstract

A personalized treatment policy requires defining the optimal treatment for each patient based on their clinical and other characteristics. Here we consider a commonly encountered situation in practice, when analyzing data from observational cohorts, that there are auxiliary variables which affect both the treatment and the outcome, yet these variables are not of primary interest to be included in a generalizable treatment strategy. Furthermore, there is not enough prior knowledge of the effect of the treatments or of the importance of the covariates for us to explicitly specify the dependency between the outcome and different covariates, thus we choose a model that is flexible enough to accommodate the possibly complex association of the outcome on the covariates. We consider observational studies with a survival outcome and propose to use Random Survival Forest with Weighted Bootstrap (RSFWB) to model the counterfactual outcomes while marginalizing over the auxiliary covariates. By maximizing the restricted mean survival time, we estimate the optimal regime for a target population based on a selected set of covariates. Simulation studies illustrate that the proposed method performs reliably across a range of different scenarios. We further apply RSFWB to a prostate cancer study.

Entities:  

Keywords:  Inverse probability weighting; optimal treatment regime; random survival forest; weighted bootstrap

Mesh:

Year:  2017        PMID: 28934002      PMCID: PMC6186022          DOI: 10.1080/10543406.2017.1380036

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  17 in total

1.  Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation.

Authors:  Peter M Rothwell
Journal:  Lancet       Date:  2005 Jan 8-14       Impact factor: 79.321

2.  The art and science of personalized medicine.

Authors:  M Piquette-Miller; D M Grant
Journal:  Clin Pharmacol Ther       Date:  2007-03       Impact factor: 6.875

3.  Doubly Robust Learning for Estimating Individualized Treatment with Censored Data.

Authors:  Y Q Zhao; D Zeng; E B Laber; R Song; M Yuan; M R Kosorok
Journal:  Biometrika       Date:  2015-03-01       Impact factor: 2.445

4.  Evaluating Random Forests for Survival Analysis using Prediction Error Curves.

Authors:  Ulla B Mogensen; Hemant Ishwaran; Thomas A Gerds
Journal:  J Stat Softw       Date:  2012-09       Impact factor: 6.440

5.  Confidence Intervals for Random Forests: The Jackknife and the Infinitesimal Jackknife.

Authors:  Stefan Wager; Trevor Hastie; Bradley Efron
Journal:  J Mach Learn Res       Date:  2014-01       Impact factor: 3.654

6.  Estimation of the optimal regime in treatment of prostate cancer recurrence from observational data using flexible weighting models.

Authors:  Jincheng Shen; Lu Wang; Jeremy M G Taylor
Journal:  Biometrics       Date:  2016-11-28       Impact factor: 2.571

7.  PERFORMANCE GUARANTEES FOR INDIVIDUALIZED TREATMENT RULES.

Authors:  Min Qian; Susan A Murphy
Journal:  Ann Stat       Date:  2011-04-01       Impact factor: 4.028

8.  Tree-based methods for individualized treatment regimes.

Authors:  E B Laber; Y Q Zhao
Journal:  Biometrika       Date:  2015-07-15       Impact factor: 2.445

9.  Recursively Imputed Survival Trees.

Authors:  Ruoqing Zhu; Michael R Kosorok
Journal:  J Am Stat Assoc       Date:  2011-12-06       Impact factor: 5.033

10.  Using Inverse Probability Bootstrap Sampling to Eliminate Sample Induced Bias in Model Based Analysis of Unequal Probability Samples.

Authors:  Matthew Nahorniak; David P Larsen; Carol Volk; Chris E Jordan
Journal:  PLoS One       Date:  2015-06-30       Impact factor: 3.240

View more
  2 in total

1.  Quantifying treatment effects using the personalized chance of longer survival.

Authors:  Ying-Qi Zhao; Mary W Redman; Michael L LeBlanc
Journal:  Stat Med       Date:  2019-09-09       Impact factor: 2.373

2.  Estimating the optimal individualized treatment rule from a cost-effectiveness perspective.

Authors:  Yizhe Xu; Tom H Greene; Adam P Bress; Brian C Sauer; Brandon K Bellows; Yue Zhang; William S Weintraub; Andrew E Moran; Jincheng Shen
Journal:  Biometrics       Date:  2020-12-09       Impact factor: 2.571

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.